About Anadys Pharma
Anadys Pharma is a company based in San Diego (United States) founded in 2001 was acquired by Roche in October 2011.. Anadys Pharma has raised $38.3 million across 2 funding rounds from investors including Roche, China Developement Bank and Atlas Venture. Anadys Pharma offers products and services including Taneral Pro, Liftactive szérum, Lipofix csepp, Start Erotique gél, and Yes Lashes szérum. Anadys Pharma operates in a competitive market with competitors including Eiger BioPharmaceuticals, Aligos Therapeutics, AusperBio, Ascentage Pharma and Bluejay Therapeutics, among others.
- Headquarter San Diego, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anadys Pharmaceuticals, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Anadys Pharma
Anadys Pharma offers a comprehensive portfolio of products and services, including Taneral Pro, Liftactive szérum, Lipofix csepp, Start Erotique gél, and Yes Lashes szérum. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Magnetic belt for posture and body alignment correction.
Serum to reduce wrinkles around eyes and face.
Drops aimed at supporting weight reduction efforts.
Gel for enhancing sexual health and experiences.
Serum for promoting eyelash growth and length.
Funding Insights of Anadys Pharma
Anadys Pharma has successfully raised a total of $38.3M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.5 million completed in June 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $17.5M
-
First Round
First Round
(25 Jul 2002)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2009 | Amount | Post-IPO - Anadys Pharma | Valuation |
investors |
|
| Jul, 2002 | Amount | Series C - Anadys Pharma | Valuation | Care Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anadys Pharma
Anadys Pharma has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche, China Developement Bank and Atlas Venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anadys Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anadys Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anadys Pharma Comparisons
Competitors of Anadys Pharma
Anadys Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eiger BioPharmaceuticals, Aligos Therapeutics, AusperBio, Ascentage Pharma and Bluejay Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Developer of therapies to treat hepatologic diseases and viral infections
|
|
| domain | founded_year | HQ Location |
Therapies for chronic hepatitis B and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for infectious diseases treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule antiviral therapeutics for hepatitis C are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anadys Pharma
Frequently Asked Questions about Anadys Pharma
When was Anadys Pharma founded?
Anadys Pharma was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Where is Anadys Pharma located?
Anadys Pharma is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Anadys Pharma a funded company?
Anadys Pharma is a funded company, having raised a total of $38.3M across 2 funding rounds to date. The company's 1st funding round was a Series C of $38.3M, raised on Jul 25, 2002.
What does Anadys Pharma do?
Anadys Pharmaceuticals was founded in 2001 as a biopharmaceutical entity based in San Diego, United States. Focus is placed on developing treatments for chronic hepatitis C, with pipeline candidates including ANA598, a non-nucleoside polymerase inhibitor, and ANA773, an oral TLR7 agonist prodrug. Additional exploration of ANA773 occurs for oncology applications. Operations center on advancing these agents through clinical development stages.
Who are the top competitors of Anadys Pharma?
Anadys Pharma's top competitors include Eiger BioPharmaceuticals, AusperBio and Finch Therapeutics.
What products or services does Anadys Pharma offer?
Anadys Pharma offers Taneral Pro, Liftactive szérum, Lipofix csepp, Start Erotique gél, and Yes Lashes szérum.
Who are Anadys Pharma's investors?
Anadys Pharma has 12 investors. Key investors include Roche, China Developement Bank, Atlas Venture, HBM Healthcare Investments, and Care Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.